Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Biologic Medical Product Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Monoclonal Antibodies
1.2.3 Colony-Stimulating Factor
1.2.4 Interferon
1.2.5 Erythropoietin
1.2.6 Insulin
1.2.7 Vaccines
1.2.8 Growth Hormones
1.2.9 Others
1.3 Market by Application
1.3.1 Global Biologic Medical Product Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Biologic Medical Product Market Perspective (2018-2034)
2.2 Biologic Medical Product Growth Trends by Region
2.2.1 Global Biologic Medical Product Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Biologic Medical Product Historic Market Size by Region (2018-2023)
2.2.3 Biologic Medical Product Forecasted Market Size by Region (2024-2034)
2.3 Biologic Medical Product Market Dynamics
2.3.1 Biologic Medical Product Industry Trends
2.3.2 Biologic Medical Product Market Drivers
2.3.3 Biologic Medical Product Market Challenges
2.3.4 Biologic Medical Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Biologic Medical Product Players by Revenue
3.1.1 Global Top Biologic Medical Product Players by Revenue (2018-2023)
3.1.2 Global Biologic Medical Product Revenue Market Share by Players (2018-2023)
3.2 Global Biologic Medical Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Biologic Medical Product Revenue
3.4 Global Biologic Medical Product Market Concentration Ratio
3.4.1 Global Biologic Medical Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Biologic Medical Product Revenue in 2024
3.5 Biologic Medical Product Key Players Head office and Area Served
3.6 Key Players Biologic Medical Product Product Solution and Service
3.7 Date of Enter into Biologic Medical Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Biologic Medical Product Breakdown Data by Type
4.1 Global Biologic Medical Product Historic Market Size by Type (2018-2023)
4.2 Global Biologic Medical Product Forecasted Market Size by Type (2024-2034)
5 Biologic Medical Product Breakdown Data by Application
5.1 Global Biologic Medical Product Historic Market Size by Application (2018-2023)
5.2 Global Biologic Medical Product Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Biologic Medical Product Market Size (2018-2034)
6.2 North America Biologic Medical Product Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Biologic Medical Product Market Size by Country (2018-2023)
6.4 North America Biologic Medical Product Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Biologic Medical Product Market Size (2018-2034)
7.2 Europe Biologic Medical Product Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Biologic Medical Product Market Size by Country (2018-2023)
7.4 Europe Biologic Medical Product Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Biologic Medical Product Market Size (2018-2034)
8.2 Asia-Pacific Biologic Medical Product Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Biologic Medical Product Market Size by Region (2018-2023)
8.4 Asia-Pacific Biologic Medical Product Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Biologic Medical Product Market Size (2018-2034)
9.2 Latin America Biologic Medical Product Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Biologic Medical Product Market Size by Country (2018-2023)
9.4 Latin America Biologic Medical Product Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Biologic Medical Product Market Size (2018-2034)
10.2 Middle East & Africa Biologic Medical Product Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Biologic Medical Product Market Size by Country (2018-2023)
10.4 Middle East & Africa Biologic Medical Product Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Detail
11.1.2 Roche Business Overview
11.1.3 Roche Biologic Medical Product Introduction
11.1.4 Roche Revenue in Biologic Medical Product Business (2018-2023)
11.1.5 Roche Recent Development
11.2 Amgen
11.2.1 Amgen Company Detail
11.2.2 Amgen Business Overview
11.2.3 Amgen Biologic Medical Product Introduction
11.2.4 Amgen Revenue in Biologic Medical Product Business (2018-2023)
11.2.5 Amgen Recent Development
11.3 AbbVie
11.3.1 AbbVie Company Detail
11.3.2 AbbVie Business Overview
11.3.3 AbbVie Biologic Medical Product Introduction
11.3.4 AbbVie Revenue in Biologic Medical Product Business (2018-2023)
11.3.5 AbbVie Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Biologic Medical Product Introduction
11.4.4 Pfizer Revenue in Biologic Medical Product Business (2018-2023)
11.4.5 Pfizer Recent Development
11.5 Sanofi-Aventis
11.5.1 Sanofi-Aventis Company Detail
11.5.2 Sanofi-Aventis Business Overview
11.5.3 Sanofi-Aventis Biologic Medical Product Introduction
11.5.4 Sanofi-Aventis Revenue in Biologic Medical Product Business (2018-2023)
11.5.5 Sanofi-Aventis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Detail
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Biologic Medical Product Introduction
11.6.4 Johnson & Johnson Revenue in Biologic Medical Product Business (2018-2023)
11.6.5 Johnson & Johnson Recent Development
11.7 Novo Nordisk
11.7.1 Novo Nordisk Company Detail
11.7.2 Novo Nordisk Business Overview
11.7.3 Novo Nordisk Biologic Medical Product Introduction
11.7.4 Novo Nordisk Revenue in Biologic Medical Product Business (2018-2023)
11.7.5 Novo Nordisk Recent Development
11.8 Eli Lilly
11.8.1 Eli Lilly Company Detail
11.8.2 Eli Lilly Business Overview
11.8.3 Eli Lilly Biologic Medical Product Introduction
11.8.4 Eli Lilly Revenue in Biologic Medical Product Business (2018-2023)
11.8.5 Eli Lilly Recent Development
11.9 Novartis
11.9.1 Novartis Company Detail
11.9.2 Novartis Business Overview
11.9.3 Novartis Biologic Medical Product Introduction
11.9.4 Novartis Revenue in Biologic Medical Product Business (2018-2023)
11.9.5 Novartis Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck Biologic Medical Product Introduction
11.10.4 Merck Revenue in Biologic Medical Product Business (2018-2023)
11.10.5 Merck Recent Development
11.11 Sun
11.11.1 Sun Company Detail
11.11.2 Sun Business Overview
11.11.3 Sun Biologic Medical Product Introduction
11.11.4 Sun Revenue in Biologic Medical Product Business (2018-2023)
11.11.5 Sun Recent Development
11.12 3sbio
11.12.1 3sbio Company Detail
11.12.2 3sbio Business Overview
11.12.3 3sbio Biologic Medical Product Introduction
11.12.4 3sbio Revenue in Biologic Medical Product Business (2018-2023)
11.12.5 3sbio Recent Development
11.13 Changchun High Tech
11.13.1 Changchun High Tech Company Detail
11.13.2 Changchun High Tech Business Overview
11.13.3 Changchun High Tech Biologic Medical Product Introduction
11.13.4 Changchun High Tech Revenue in Biologic Medical Product Business (2018-2023)
11.13.5 Changchun High Tech Recent Development
11.14 CP Guojian
11.14.1 CP Guojian Company Detail
11.14.2 CP Guojian Business Overview
11.14.3 CP Guojian Biologic Medical Product Introduction
11.14.4 CP Guojian Revenue in Biologic Medical Product Business (2018-2023)
11.14.5 CP Guojian Recent Development
11.15 Biotech
11.15.1 Biotech Company Detail
11.15.2 Biotech Business Overview
11.15.3 Biotech Biologic Medical Product Introduction
11.15.4 Biotech Revenue in Biologic Medical Product Business (2018-2023)
11.15.5 Biotech Recent Development
11.16 Gelgen
11.16.1 Gelgen Company Detail
11.16.2 Gelgen Business Overview
11.16.3 Gelgen Biologic Medical Product Introduction
11.16.4 Gelgen Revenue in Biologic Medical Product Business (2018-2023)
11.16.5 Gelgen Recent Development
11.17 Innovent
11.17.1 Innovent Company Detail
11.17.2 Innovent Business Overview
11.17.3 Innovent Biologic Medical Product Introduction
11.17.4 Innovent Revenue in Biologic Medical Product Business (2018-2023)
11.17.5 Innovent Recent Development
11.18 Ganlee
11.18.1 Ganlee Company Detail
11.18.2 Ganlee Business Overview
11.18.3 Ganlee Biologic Medical Product Introduction
11.18.4 Ganlee Revenue in Biologic Medical Product Business (2018-2023)
11.18.5 Ganlee Recent Development
11.19 United Laboratories
11.19.1 United Laboratories Company Detail
11.19.2 United Laboratories Business Overview
11.19.3 United Laboratories Biologic Medical Product Introduction
11.19.4 United Laboratories Revenue in Biologic Medical Product Business (2018-2023)
11.19.5 United Laboratories Recent Development
11.20 Teva Pharmaceutical
11.20.1 Teva Pharmaceutical Company Detail
11.20.2 Teva Pharmaceutical Business Overview
11.20.3 Teva Pharmaceutical Biologic Medical Product Introduction
11.20.4 Teva Pharmaceutical Revenue in Biologic Medical Product Business (2018-2023)
11.20.5 Teva Pharmaceutical Recent Development
11.21 MYLAN
11.21.1 MYLAN Company Detail
11.21.2 MYLAN Business Overview
11.21.3 MYLAN Biologic Medical Product Introduction
11.21.4 MYLAN Revenue in Biologic Medical Product Business (2018-2023)
11.21.5 MYLAN Recent Development
11.22 Sun Pharma
11.22.1 Sun Pharma Company Detail
11.22.2 Sun Pharma Business Overview
11.22.3 Sun Pharma Biologic Medical Product Introduction
11.22.4 Sun Pharma Revenue in Biologic Medical Product Business (2018-2023)
11.22.5 Sun Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Biologic Medical Product Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Monoclonal Antibodies
Table 3. Key Players of Colony-Stimulating Factor
Table 4. Key Players of Interferon
Table 5. Key Players of Erythropoietin
Table 6. Key Players of Insulin
Table 7. Key Players of Vaccines
Table 8. Key Players of Growth Hormones
Table 9. Key Players of Others
Table 10. Global Biologic Medical Product Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 11. Global Biologic Medical Product Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 12. Global Biologic Medical Product Market Size by Region (2018-2023) & (US$ Million)
Table 13. Global Biologic Medical Product Market Share by Region (2018-2023)
Table 14. Global Biologic Medical Product Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 15. Global Biologic Medical Product Market Share by Region (2024-2034)
Table 16. Biologic Medical Product Market Trends
Table 17. Biologic Medical Product Market Drivers
Table 18. Biologic Medical Product Market Challenges
Table 19. Biologic Medical Product Market Restraints
Table 20. Global Biologic Medical Product Revenue by Players (2018-2023) & (US$ Million)
Table 21. Global Biologic Medical Product Market Share by Players (2018-2023)
Table 22. Global Top Biologic Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medical Product as of 2024)
Table 23. Ranking of Global Top Biologic Medical Product Companies by Revenue (US$ Million) in 2024
Table 24. Global 5 Largest Players Market Share by Biologic Medical Product Revenue (CR5 and HHI) & (2018-2023)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Biologic Medical Product Product Solution and Service
Table 27. Date of Enter into Biologic Medical Product Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Biologic Medical Product Market Size by Type (2018-2023) & (US$ Million)
Table 30. Global Biologic Medical Product Revenue Market Share by Type (2018-2023)
Table 31. Global Biologic Medical Product Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 32. Global Biologic Medical Product Revenue Market Share by Type (2024-2034)
Table 33. Global Biologic Medical Product Market Size by Application (2018-2023) & (US$ Million)
Table 34. Global Biologic Medical Product Revenue Market Share by Application (2018-2023)
Table 35. Global Biologic Medical Product Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 36. Global Biologic Medical Product Revenue Market Share by Application (2024-2034)
Table 37. North America Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. North America Biologic Medical Product Market Size by Country (2018-2023) & (US$ Million)
Table 39. North America Biologic Medical Product Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 41. Europe Biologic Medical Product Market Size by Country (2018-2023) & (US$ Million)
Table 42. Europe Biologic Medical Product Market Size by Country (2024-2034) & (US$ Million)
Table 43. Asia-Pacific Biologic Medical Product Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 44. Asia-Pacific Biologic Medical Product Market Size by Region (2018-2023) & (US$ Million)
Table 45. Asia-Pacific Biologic Medical Product Market Size by Region (2024-2034) & (US$ Million)
Table 46. Latin America Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Latin America Biologic Medical Product Market Size by Country (2018-2023) & (US$ Million)
Table 48. Latin America Biologic Medical Product Market Size by Country (2024-2034) & (US$ Million)
Table 49. Middle East & Africa Biologic Medical Product Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 50. Middle East & Africa Biologic Medical Product Market Size by Country (2018-2023) & (US$ Million)
Table 51. Middle East & Africa Biologic Medical Product Market Size by Country (2024-2034) & (US$ Million)
Table 52. Roche Company Detail
Table 53. Roche Business Overview
Table 54. Roche Biologic Medical Product Product
Table 55. Roche Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 56. Roche Recent Development
Table 57. Amgen Company Detail
Table 58. Amgen Business Overview
Table 59. Amgen Biologic Medical Product Product
Table 60. Amgen Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 61. Amgen Recent Development
Table 62. AbbVie Company Detail
Table 63. AbbVie Business Overview
Table 64. AbbVie Biologic Medical Product Product
Table 65. AbbVie Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 66. AbbVie Recent Development
Table 67. Pfizer Company Detail
Table 68. Pfizer Business Overview
Table 69. Pfizer Biologic Medical Product Product
Table 70. Pfizer Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 71. Pfizer Recent Development
Table 72. Sanofi-Aventis Company Detail
Table 73. Sanofi-Aventis Business Overview
Table 74. Sanofi-Aventis Biologic Medical Product Product
Table 75. Sanofi-Aventis Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 76. Sanofi-Aventis Recent Development
Table 77. Johnson & Johnson Company Detail
Table 78. Johnson & Johnson Business Overview
Table 79. Johnson & Johnson Biologic Medical Product Product
Table 80. Johnson & Johnson Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 81. Johnson & Johnson Recent Development
Table 82. Novo Nordisk Company Detail
Table 83. Novo Nordisk Business Overview
Table 84. Novo Nordisk Biologic Medical Product Product
Table 85. Novo Nordisk Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 86. Novo Nordisk Recent Development
Table 87. Eli Lilly Company Detail
Table 88. Eli Lilly Business Overview
Table 89. Eli Lilly Biologic Medical Product Product
Table 90. Eli Lilly Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 91. Eli Lilly Recent Development
Table 92. Novartis Company Detail
Table 93. Novartis Business Overview
Table 94. Novartis Biologic Medical Product Product
Table 95. Novartis Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 96. Novartis Recent Development
Table 97. Merck Company Detail
Table 98. Merck Business Overview
Table 99. Merck Biologic Medical Product Product
Table 100. Merck Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 101. Merck Recent Development
Table 102. Sun Company Detail
Table 103. Sun Business Overview
Table 104. Sun Biologic Medical Product Product
Table 105. Sun Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 106. Sun Recent Development
Table 107. 3sbio Company Detail
Table 108. 3sbio Business Overview
Table 109. 3sbio Biologic Medical Product Product
Table 110. 3sbio Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 111. 3sbio Recent Development
Table 112. Changchun High Tech Company Detail
Table 113. Changchun High Tech Business Overview
Table 114. Changchun High Tech Biologic Medical Product Product
Table 115. Changchun High Tech Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 116. Changchun High Tech Recent Development
Table 117. CP Guojian Company Detail
Table 118. CP Guojian Business Overview
Table 119. CP Guojian Biologic Medical Product Product
Table 120. CP Guojian Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 121. CP Guojian Recent Development
Table 122. Biotech Company Detail
Table 123. Biotech Business Overview
Table 124. Biotech Biologic Medical Product Product
Table 125. Biotech Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 126. Biotech Recent Development
Table 127. Gelgen Company Detail
Table 128. Gelgen Business Overview
Table 129. Gelgen Biologic Medical Product Product
Table 130. Gelgen Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 131. Gelgen Recent Development
Table 132. Innovent Company Detail
Table 133. Innovent Business Overview
Table 134. Innovent Biologic Medical Product Product
Table 135. Innovent Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 136. Innovent Recent Development
Table 137. Ganlee Company Detail
Table 138. Ganlee Business Overview
Table 139. Ganlee Biologic Medical Product Product
Table 140. Ganlee Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 141. Ganlee Recent Development
Table 142. United Laboratories Company Detail
Table 143. United Laboratories Business Overview
Table 144. United Laboratories Biologic Medical Product Product
Table 145. United Laboratories Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 146. United Laboratories Recent Development
Table 147. Teva Pharmaceutical Company Detail
Table 148. Teva Pharmaceutical Business Overview
Table 149. Teva Pharmaceutical Biologic Medical Product Product
Table 150. Teva Pharmaceutical Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 151. Teva Pharmaceutical Recent Development
Table 152. MYLAN Company Detail
Table 153. MYLAN Business Overview
Table 154. MYLAN Biologic Medical Product Product
Table 155. MYLAN Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 156. MYLAN Recent Development
Table 157. Sun Pharma Company Detail
Table 158. Sun Pharma Business Overview
Table 159. Sun Pharma Biologic Medical Product Product
Table 160. Sun Pharma Revenue in Biologic Medical Product Business (2018-2023) & (US$ Million)
Table 161. Sun Pharma Recent Development
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Biologic Medical Product Market Size Comparison by Type (2023-2034) & (US$ Million)
Figure 2. Global Biologic Medical Product Market Share by Type: 2024 VS 2034
Figure 3. Monoclonal Antibodies Features
Figure 4. Colony-Stimulating Factor Features
Figure 5. Interferon Features
Figure 6. Erythropoietin Features
Figure 7. Insulin Features
Figure 8. Vaccines Features
Figure 9. Growth Hormones Features
Figure 10. Others Features
Figure 11. Global Biologic Medical Product Market Size Comparison by Application (2023-2034) & (US$ Million)
Figure 12. Global Biologic Medical Product Market Share by Application: 2024 VS 2034
Figure 13. Tumor Case Studies
Figure 14. Diabetes Case Studies
Figure 15. Cardiovascular Case Studies
Figure 16. Hemophilia Case Studies
Figure 17. Others Case Studies
Figure 18. Biologic Medical Product Report Years Considered
Figure 19. Global Biologic Medical Product Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 20. Global Biologic Medical Product Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 21. Global Biologic Medical Product Market Share by Region: 2024 VS 2034
Figure 22. Global Biologic Medical Product Market Share by Players in 2024
Figure 23. Global Top Biologic Medical Product Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biologic Medical Product as of 2024)
Figure 24. The Top 10 and 5 Players Market Share by Biologic Medical Product Revenue in 2024
Figure 25. North America Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. North America Biologic Medical Product Market Share by Country (2018-2034)
Figure 27. United States Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Canada Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Europe Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Europe Biologic Medical Product Market Share by Country (2018-2034)
Figure 31. Germany Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. France Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. U.K. Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Italy Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. Russia Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Nordic Countries Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. Asia-Pacific Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Asia-Pacific Biologic Medical Product Market Share by Region (2018-2034)
Figure 39. China Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Japan Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 41. South Korea Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Southeast Asia Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. India Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Australia Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. Latin America Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Latin America Biologic Medical Product Market Share by Country (2018-2034)
Figure 47. Mexico Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 48. Brazil Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Biologic Medical Product Market Share by Country (2018-2034)
Figure 51. Turkey Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Biologic Medical Product Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Roche Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 54. Amgen Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 55. AbbVie Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 56. Pfizer Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 57. Sanofi-Aventis Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 58. Johnson & Johnson Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 59. Novo Nordisk Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 60. Eli Lilly Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 61. Novartis Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 62. Merck Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 63. Sun Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 64. 3sbio Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 65. Changchun High Tech Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 66. CP Guojian Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 67. Biotech Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 68. Gelgen Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 69. Innovent Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 70. Ganlee Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 71. United Laboratories Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 72. Teva Pharmaceutical Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 73. MYLAN Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 74. Sun Pharma Revenue Growth Rate in Biologic Medical Product Business (2018-2023)
Figure 75. Bottom-up and Top-down Approaches for This Report
Figure 76. Data Triangulation
Figure 77. Key Executives Interviewed